Category: Arthritis News

Grünenthal is a research-driven pharmaceutical company specialising in the provision of treatments for managing pain. We are a leading global provider of innovative treatments and state-of-the-art technologies for people living with pain in the UK and around the world.

Our purpose is to change lives for the better. We are focusing all activities and efforts on moving towards our vision for a World Free of Pain.

Grunenthal UK, Ltd.

As the waiting lists continue to rise there are challenges in managing the surgical workload created from pausing services during the ongoing COVID-19 pandemic. Foot and ankle complications arise in 30% of the population and surgical intervention can give an immediate solution to many as well as providing an alternative intervention for those receiving continued conservative care. Podiatric surgery has been established as a specialist service for over 40 years and can assist in providing a cost-effective solution for reducing elective foot surgery waiting times.…

Read more of this article

Throughout its 95 years, the British Chiropractic Association (BCA) has taken the lead in both establishing chiropractic and shaping the profession in the UK. The Association’s direction has always been driven by the needs of the profession with a view to the future; always for the benefit of its practitioners and their patients.

After changes to the senior leadership team two years ago, the Association is now at the point where establishing a new strategic position will be paramount in moving forward in its development.…

Read more of this article

School toolkit launched to support pupils with hypermobility-related disorders

The Ehlers-Danlos Support UK (EDS UK) and the Hypermobility Syndromes Association (HMSA) have together launched an online toolkit for schools to support pupils with hypermobility-related disorders.

The new website aims to provide school staff with simple information about symptomatic hypermobility and the Ehlers-Danlos syndromes (EDS) and how they may affect primary and secondary pupils at school. It emphasises that the conditions affect children and young people in different ways and often, simple, low-cost adjustments can make a big difference.…

Read more of this article

The Royal Osteoporosis Society (ROS) has launched a new Bone Health Accreditation Scheme, which is aiming to help people to make good choices for their bones by displaying a ‘Bone Health Approved’ logo on products.

A wide range of products and services can now apply to the use the logo on their packaging and marketing materials, including foods, beverages, supplements and living aids. ROS bone health experts will then assess the claims that a product is making about bone health, and once approved, organisations can use the logo to show that their product or service is good for bones.…

Read more of this article

A new partnership between the Health Innovation Network (HIN) and Orthopaedic Research UK (ORUK) has secured the future of the award-winning ESCAPE-pain programme, which helps people with knee, hip and back pain.

The ESCAPE-pain programme, which stands for Enabling Self-Management and Coping with Arthritic Pain using Exercise (ESCAPE), was developed by Professor Mike Hurley at St George’s University of London and Kingston University to help people with knee, hip and back pain. In 2013 it was identified as a local innovation that was ready for adoption by the Health Innovation Network (HIN), the Academic Health Science Network for south London.…

Read more of this article